ACT-AEC First Annual Meeting

At the ACT-AEC First Annual Meeting, ACT-AEC invited 48 Canadian biotechnology companies to present their work to members of the consortium. ACT-AEC is proud to share the experiences of these companies in connecting with ACT-AEC’s consortium partners. To connect with ACT-AEC, contact us.

RFA 5 Announcement

November 22, 2024 No Comments

The Accelerating Clinical Trials (ACT) Consortium recently held a competition to bring high-impact randomized controlled trials to Canada that were initiated and are led by

Group Selected to Run Pan-Canadian Single Research Ethics Board Review Process

November 12, 2024 No Comments

International review panel selects CanReview to set up, initiate, and conduct a pan-Canadian single REB review and approval process with strict timelines. The Accelerating Clinical

Canadian Biotech Opportunity

July 16, 2024 No Comments

Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we are seeking Canadian biotechnology companies

New Pan-Canadian Data and Sample Transfer Agreement

June 4, 2024 No Comments

New pan-Canadian data and sample transfer agreement a game-changer for clinical research “We’ve built a high-speed legal highway for researchers to use to share their

Upcoming Webinars

March 6, 2024 No Comments

For more information about upcoming webinars, please see the ACT Education page!

ACT-AEC First Annual Meeting

November 10, 2023 No Comments

At the ACT-AEC First Annual Meeting, ACT-AEC invited 48 Canadian biotechnology companies to present their work to members of the consortium. ACT-AEC is proud to